Numerous hereditary disorders linked to hair loss affect people globally. Alopecia Areata (AA) is included in the group of disorders referred to as autoimmune diseases. Usually, this condition manifests as patchy or circular bald patches that leave no scars. It occasionally also causes the nails to become pitted or brittle.
According to the report of NIH in 2021, The prevalence of alopecia areata is 100–200 per 100,000 people, and the lifetime risk is roughly 2%. For men and women, respectively, the average age at which alopecia areata is diagnosed is 32 and 36 years old.
Alopecia areata affects about 20.2 persons per 100,000 person-years on average. By the time they are 50 years old, about 50,000 out of 100,000 Caucasian males have androgenetic alopecia. At 70 years of age, this number increases to ~80,000 per 100,000.
Alopecia areata, sometimes called alopecia, is a skin disease that is immune-mediated and chronic. It is characterized by sudden hair loss on the scalp, beard, and occasionally the eyebrows, eyelashes, and body hair. Another way to put it is as bald patches or spots. The erratic nature of this patchy hair loss is attributed to its sudden recurrence of hair growth that resumes at any time.
The extent of hair loss and other symptoms determine the type of alopecia areata. The most prevalent type of alopecia areata is patchy. One or more coin-sized patches of hair loss on the scalp or body are its defining feature. Alopecia totalis is the term used to describe complete scalp hair loss. When a patient loses all of the hair on the body including on the face and scalp have alopecia universalis.
The sudden and unexpected thinning of hair occurs throughout the scalp, not just in one spot or area when diffuse alopecia areata. Either male or female pattern hair loss appears. Another name for it is alopecia areata incognita. Ophiasis is a condition where there is a band-like loss of hair around the outside of the head, especially where the temporal and occipital bones meet. A band of hair loss around the sides and lower back of the scalp is a symptom of ophiasis alopecia.
Causes
The most frequent cause of hair loss is an aging-related genetic condition. Male-pattern baldness, female-pattern baldness, and androgenic alopecia are the names given to this condition. There are other conditions, such as hormonal changes brought on by pregnancy, childbirth, menopause, and thyroid issues, that result in either temporary or permanent hair loss. Medical conditions include ringworm, an immune system-related alopecia areata that results in patchy hair loss, and trichotillomania, a disorder that causes excessive hair pulling.
It is also caused by to side effects of medicines used in the treatment of cancer, arthritis, depression, heart problems, gout, and high blood pressure or due to radiation therapy and very stressful events. A common side effect of physical or emotional shock is general hair thinning, which occurs in many cases several months later. This kind of hair loss is transient.
Depending on the underlying cause, Alopecia Areata appears with a variety of symptoms. It strikes suddenly or gradually, affecting the entire body or just the scalp.
Some of the signs and symptoms include:
Gradual thinning on head: The most prevalent form of hair loss that affects people as they age is gradual thinning on top of the head. Men's hair frequently starts to recede at their forehead hairline. In women's hair, the part usually gets wider. A receding hairline (frontal fibrosing alopecia) is a pattern of hair loss that is becoming more and more common in older women.
Patchy or circular bald spots: On the scalp, beard, or eyebrows, some people experience patchy or circular bald spots. Before the hair falls out, the skin starts to hurt or become itchy.
Unexpected hair looseness: Hairs suddenly become loose due to an emotional or physical shock. When brushing or washing hair, or even just after giving it a little tug, handfuls of hair fall out. Although temporary, this type of hair loss typically results in overall hair thinning.
Total body baldness: Hair loss is a side effect of certain medical conditions and treatments, like chemotherapy for cancer. Usually, the hair grows back.
Scaling patches that extend throughout the scalp are indicative of ringworm. Broken hair, redness, swelling, and occasionally seeping accompany it.
Treatment Analysis for Alopecia Areata
Certain types of hair loss have viable therapies available. It stops or at least slows hair loss. Both medication and surgery are used as treatments for hair loss.
Medications
Surgery and Other Procedures
Acupuncture, aromatherapy, vitamins, and supplements like zinc and biotin, essential oils like coconut, tea tree, and castor oil, and applying onion juice to the scalp are some natural treatments, and probiotics are examples of possible alternative treatments. Dietary adjustments are also beneficial in treating alopecia areata.
Treatment Market Players |
Products |
F. Hoffmann-la roche ltd. |
LITFULO™ |
Pfizer |
Olumiant® |
Teva Pharmaceutical Industries Ltd. |
Rogaine® |
Sanofi |
Gainextra® |
GlaxoSmithKline plc |
JAKAFI™ |
Novartis AG |
Xeljanz® |
Dr. Reddy’s Laboratories Ltd. |
Dithranol® |
Merck & co. Ranbaxy Laboratories Ltd |
irestore® Hair Growth System |
Bausch Health Companies Inc |
Theradome® |
Eli Lilly Australia Pty Ltd |
CTP 543 |
iRestore Laser India |
|
Current updates to the regulatory guidelines offered by DiseaseLandscape Insights services are very beneficial for expanding companies. These updates make sure that businesses streamline their marketing and product development processes, stay compliant with evolving industry standards, and stay out of potential legal hotspots.
The DiseaseLandscape Insights consultancy firm provides valuable support in future market trends on the development of new pharmaceutical products. This support helps to streamline the planning and execution of clinical trials of novel medications and treatments, implement effective patient recruitment strategies, ensure regulatory compliance, and increase the likelihood of successful trial outcomes.
The below table gives information about some currently ongoing clinical trials, including their study titles and respective stages:
PHASE 1 (Human Pharmacology) |
PHASE 2 (Therapeutic Exploratory Trail) |
PHASE 3 (Therapeutic Confirmatory Trial) |
PHASE 4 (Post Marketing Surveillance) |
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia |
Investigate the Efficacy and Safety of Farudodstat Compared with Its Placebo in Adult Alopecia Areata Participants |
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants with Severe Alopecia Areata |
Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata |
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adult Alopecia Areata Participants |
Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata |
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults with Alopecia Areata |
Hydraderm for Androgenic Alopecia |
A Study with Jaktinib Hydrochloride Cream Applied Topically to Subjects with Alopecia Areata |
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects with Moderate-to-Severe Alopecia Areata |
DPCP for the Treatment of Alopecia Areata |
Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study |
A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects |
Clinical Application of Stem Cell Educator Therapy in Alopecia Areata |
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age with Alopecia Areata |
|
|
A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients with Androgenetic Alopecia |
Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study) |
|
Understanding market dynamics and spotting business growth opportunities are crucial tasks for which DiseaseLandscape Insight (DLI) Services is essential. These services offer a thorough analysis of new trends, prevalent illnesses, and their effects on different industries, empowering businesses to make wise decisions.
Companies get valuable insights into the demand for products and services within the healthcare sector by monitoring various factors such as disease causes, prevalence, diagnostic options, treatment patterns, regulatory guidelines updates, clinical trial assessments, and research and development advances. Equipped with this understanding, companies optimize their growth potential and maintain a competitive edge in the market by carefully positioning themselves, creating focused marketing campaigns, and funding the creation of novel solutions.
With the help of DiseaseLandscape Insight Services, businesses take advantage of expanding opportunities by arming themselves with critical healthcare market information. Through a comprehensive understanding of disease patterns, treatment requirements, and technological advancements, companies customize their offerings to meet changing market needs and promote growth and success.
How we can help?